We found that galectin-1 levels were higher in the SIRD group (compared with other type 2 diabetes subgroups), and, among individuals with SIRD, higher galectin-1 levels were cross-sectionally associated with lower eGFR. This evidence concerns the gene LGALS1 and type 2 diabetes mellitus.